Rep. Eric Swalwell has officially announced his candidacy for the 2026 California governor's race on 'Jimmy Kimmel Live.' With over 20 candidates vying for the position, Swalwell aims to tackle high prices and support Californians in need.
Democratic Representative Eric Swalwell has officially launched his campaign for California governor, promising to combat high prices and protect residents from federal overreach. His announcement comes amid ongoing tensions with Trump.
In a recent Fox News interview, President Trump insisted the U.S. economy is thriving, dismissing negative polls as 'fake news.' He defended his policies, including a controversial 50-year mortgage option, amidst rising inflation and gas prices.
Trump proposes a $2,000 dividend for Americans, funded by tariff revenues, as he aims to address high prices and national debt. But can this ambitious plan actually work?
President Trump hints at $2,000 checks for Americans funded by tariffs, echoing pandemic relief measures. But could this lead to higher prices and inflation? Find out the implications!
As furniture prices soar due to inflation and tariffs, many consumers are grappling with how to refresh their living spaces without breaking the bank. Discover the surprising trends and insights from industry experts.
Billionaire John Catsimatidis had plans to move his business to New Jersey if socialist candidate Zohran Mamdani won the NYC mayoral race. Now reevaluating his options, he expresses concerns over the future of his stores amidst rising food prices.
Get ready for a smart home revolution! IKEA is launching 21 innovative Matter-compatible products, including smart bulbs, sensors, and more—all at affordable prices. Discover how these devices can enhance your living space!
Eli Lilly & Co. and Novo Nordisk A/S have struck a deal with the Trump administration to lower prices for their popular weight-loss drugs, Zepbound and Wegovy, while gaining tariff relief and expanding Medicare access. This agreement aims to increase availability for older Americans.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.